Ledger.Open graph →
SEC Form D · filed October 8, 2021

Nerio Therapeutics, Inc

Offering
$10.0M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LA JOLLA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Jay J. Lichter, Ph.D · La Jolla, CADirectorTighe J. Reardon · La Jolla, CAExec · DirectorStefan J. Heller · La Jolla, CADirectorSanford J. Madigan, Ph.D · La Jolla, CAExec · DirectorSanford J. Madigan, Ph.D · La Jolla, CAExec · DirectorJay J. Lichter, Ph.D · La Jolla, CADirectorTighe J. Reardon · La Jolla, CAExec · DirectorStefan J. Heller · La Jolla, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗